Skip to main content

Table 1 Origin and sample size of metabolomics studies for LN

From: Metabolomics and biomarkers for lupus nephritis – a systematic review

Author, year

Country

LN

n=191

Control

n=262

(Kalantari et al. 2019)

Iran

14

21

(Romick-Rosendale et al. 2011)

USA

14

10

(Li et al. 2017)

China

32

58

(Guleria et al. 2016)

India

40

52

(Zhang et al. 2022)

USA

30

30

(Zhang et al. 2022)

USA

43

73

(Ganguly et al. 2020)

India

18

18